Abstract
High-throughput screening to discover small-molecule modulators of enzymes typically relies on highly tailored substrate assays, which are not available for poorly characterized enzymes. Here we report a general, substrate-free method for identifying inhibitors of uncharacterized enzymes. The assay measures changes in the kinetics of covalent active-site labeling with broad-spectrum, fluorescent probes in the presence of inhibitors by monitoring the fluorescence polarization signal. We show that this technology is applicable to enzymes from at least two mechanistic classes, regardless of their degree of functional annotation, and can be coupled with secondary proteomic assays that use competitive activity-based profiling to rapidly determine the specificity of screening hits. Using this method, we identify the bioactive alkaloid emetine as a selective inhibitor of the uncharacterized cancer-associated hydrolase RBBP9. Furthermore, we show that the detoxification enzyme GSTO1, also implicated in cancer, is inhibited by several electrophilic compounds found in public libraries, some of which display high selectivity for this protein.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Mechanistic evaluation and transcriptional signature of a glutathione S-transferase omega 1 inhibitor
Nature Communications Open Access 05 October 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout






Change history
08 May 2009
In the version of the article initially published, the IC50 value of cephaeline is given as 2.7 μM in Figure 3d. The correct value is 27 μM. The error has been corrected in the HTML and PDF versions of the article.
References
Inglese, J. et al. High-throughput screening assays for the identification of chemical probes. Nat. Chem. Biol. 3, 466–479 (2007).
Shelat, A.A. & Guy, R.K. Scaffold composition and biological relevance of screening libraries. Nat. Chem. Biol. 3, 442–446 (2007).
Ahn, K. et al. A novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity. Biochemistry 46, 13019–13030 (2007).
Jo, E. et al. S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate. Chem. Biol. 12, 703–715 (2005).
Dolma, S., Lessnick, S.L., Hahn, W.C. & Stockwell, B.R. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell 3, 285–296 (2003).
Galperin, M.Y. & Koonin, E.V. 'Conserved hypothetical' proteins: prioritization of targets for experimental study. Nucleic Acids Res. 32, 5452–5463 (2004).
Woitach, J.T., Zhang, M., Niu, C.H. & Thorgeirsson, S.S. A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability. Nat. Genet. 19, 371–374 (1998).
Rao, M. & Sockanathan, S. Transmembrane protein GDE2 induces motor neuron differentiation in vivo. Science 309, 2212–2215 (2005).
Semba, S. et al. Biological functions of mammalian NIT1, the counterpart of the invertebrate NITFHIT rosetta stone protein, a possible tumor suppressor. J. Biol. Chem. 281, 28244–28253 (2006).
Evans, M.J. & Cravatt, B.F. Mechanism-based profiling of enzyme families. Chem. Rev. 106, 3279–3301 (2006).
Cravatt, B.F., Wright, A.T. & Kozarich, J.W. Activity-based protein profiling: from enzyme chemistry to proteomic chemistry. Annu. Rev. Biochem. 77, 383–414 (2008).
Jessani, N., Liu, Y., Humphrey, M. & Cravatt, B.F. Enzyme activity profiles of the secreted and membrane proteome that depict cancer invasiveness. Proc. Natl. Acad. Sci. USA 99, 10335–10340 (2002).
Jessani, N. et al. A streamlined platform for high-content functional proteomics of primary human specimens. Nat. Methods 2, 691–697 (2005).
Joyce, J.A. et al. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 5, 443–453 (2004).
Adam, G.C., Sorensen, E.J. & Cravatt, B.F. Proteomic profiling of mechanistically distinct enzyme classes using a common chemotype. Nat. Biotechnol. 20, 805–809 (2002).
Greenbaum, D.C. et al. A role for the protease falcipain 1 in host cell invasion by the human malaria parasite. Science 298, 2002–2006 (2002).
Blankman, J.L., Simon, G.S. & Cravatt, B.F. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-Arachidonoylglycerol. Chem. Biol. 14, 1347–1356 (2007).
Barglow, K.T. & Cravatt, B.F. Substrate mimicry in an activity-based probe that targets the nitrilase family of enzymes. Angew. Chem. Int. Edn. Engl. 45, 7408–7411 (2006).
Leung, D., Hardouin, C., Boger, D.L. & Cravatt, B.F. Discovering potent and selective reversible inhibitors of enzymes in complex proteomes. Nat. Biotechnol. 21, 687–691 (2003).
Chiang, K.P., Niessen, S., Saghatelian, A. & Cravatt, B.F. An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling. Chem. Biol. 13, 1041–1050 (2006).
Li, W., Blankman, J.L. & Cravatt, B.F. A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases. J. Am. Chem. Soc. 129, 9594–9595 (2007).
Owicki, J.C. Fluorescence polarization and anisotropy in high-throughput screening: perspectives and primer. J. Biomol. Screen. 5, 297–306 (2000).
Vorobiev, S.M. et al. Crystal structure of human retinoblastoma binding protein 9. Proteins 74, 526–529 (2008).
Patricelli, M.P., Giang, D.K., Stamp, L.M. & Burbaum, J.J. Direct visualization of serine hydrolase activities in complex proteome using fluorescent active site-directed probes. Proteomics 1, 1067–1071 (2001).
Liu, Y., Patricelli, M.P. & Cravatt, B.F. Activity-based protein profiling: the serine hydrolases. Proc. Natl. Acad. Sci. USA 96, 14694–14699 (1999).
Hoover, H.S., Blankman, J.L., Niessen, S. & Cravatt, B.F. Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling. Bioorg. Med. Chem. Lett. 18, 5838–5841 (2008).
Saario, S.M. et al. Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes. Chem. Biol. 12, 649–656 (2005).
Feng, B.Y., Shelat, A., Doman, T.N., Guy, R.K. & Shoichet, B.K. High-throughput assays for promiscuous inhibitors. Nat. Chem. Biol. 1, 146–148 (2005).
Feng, B.Y. et al. A high-throughput screen for aggregation-based inhibition in a large compound library. J. Med. Chem. 50, 2385–2390 (2007).
Feng, B.Y. & Shoichet, B.K. A detergent-based assay for the detection of promiscuous inhibitors. Nat. Protoc. 1, 550–553 (2006).
Boon-Unge, K. et al. Emetine regulates the alternative splicing of Bcl-x through a protein phosphatase 1-dependent mechanism. Chem. Biol. 14, 1386–1392 (2007).
Keiser, M.J. et al. Relating protein pharmacology by ligand chemistry. Nat. Biotechnol. 25, 197–206 (2007).
Grollman, A.P. Structural basis for inhibition of protein synthesis by emetine and cycloheximide based on an analogy between ipecac alkaloids and glutarimide antibiotics. Proc. Natl. Acad. Sci. USA 56, 1867–1874 (1966).
Gupta, R.S. & Siminovitch, L. The molecular basis of emetine resistance in Chinese hamster ovary cells: alteration in the 40S ribosomal subunit. Cell 10, 61–66 (1977).
Monks, T.J. & Jones, D.C. The metabolism and toxicity of quinones, quinonimines, quinone methides, and quinone-thioethers. Curr. Drug Metab. 3, 425–438 (2002).
Hayes, J.D., Flanagan, J.U. & Jowsey, I.R. Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 45, 51–88 (2005).
Yan, X.D., Pan, L.Y., Yuan, Y., Lang, J.H. & Mao, N. Identification of platinum-resistance associated proteins through proteomic analysis of human ovarian cancer cells and their platinum-resistant sublines. J. Proteome Res. 6, 772–780 (2007).
Board, P.G. et al. Identification, characterization, and crystal structure of the omega class glutathione transferases. J. Biol. Chem. 275, 24798–24806 (2000).
Whitbread, A.K. et al. Characterization of the omega class of glutathione transferases. Methods Enzymol. 401, 78–99 (2005).
Zhang, K. & Wong, K.P. Glutathione conjugation of chlorambucil: measurement and modulation by plant polyphenols. Biochem. J. 325, 417–422 (1997).
Adam, G.C., Sorensen, E.J. & Cravatt, B.F. Trifunctional chemical probes for the consolidated detection and identification of enzyme activities from complex proteomes. Mol. Cell. Proteomics 1, 828–835 (2002).
Liu, S., Cerione, R.A. & Clardy, J. Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity. Proc. Natl. Acad. Sci. USA 99, 2743–2747 (2002).
Board, P.G. et al. S-(4-Nitrophenacyl)glutathione is a specific substrate for glutathione transferase omega 1–1. Anal. Biochem. 374, 25–30 (2008).
Torta, F., Usuelli, V., Malgaroli, A. & Bachi, A. Proteomic analysis of protein S-nitrosylation. Proteomics 8, 4484–4494 (2008).
Poole, L.B. & Nelson, K.J. Discovering mechanisms of signaling-mediated cysteine oxidation. Curr. Opin. Chem. Biol. 12, 18–24 (2008).
Vila, A. et al. Identification of protein targets of 4-hydroxynonenal using click chemistry for ex vivo biotinylation of azido and alkynyl derivatives. Chem. Res. Toxicol. 21, 432–444 (2008).
Hafner, M. et al. Inhibition of cytohesins by SecinH3 leads to hepatic insulin resistance. Nature 444, 941–944 (2006).
Antczak, C., Radu, C. & Djaballah, H. A profiling platform for the identification of selective metalloprotease inhibitors. J. Biomol. Screen. 13, 285–294 (2008).
Patricelli, M.P. et al. Functional interrogation of the kinome using nucleotide acyl phosphates. Biochemistry 46, 350–358 (2007).
Chandonia, J.M. & Brenner, S.E. The impact of structural genomics: expectations and outcomes. Science 311, 347–351 (2006).
Acknowledgements
We thank the Cravatt laboratory for helpful discussions. We are grateful to S. Schürer and P. Baillargeon for help purchasing emetine analogs, to S. Tully for assistance with the synthesis of 4NPG and to J. Garfunkle for assembly of the Boger chemical library. Full-length cDNA encoding human RBBP9 was a gift of the Cheresh laboratory (UCSD). This work was supported by the National Institutes of Health (CA132630, MH084512), a National Science Foundation Predoctoral Fellowship (D.A.B.), and the Skaggs Institute for Chemical Biology.
Author information
Authors and Affiliations
Contributions
D.A.B. performed experiments. D.A.B., S.J.B., H.R. and B.F.C. designed experiments and analyzed data. D.A.B. and B.F.C. wrote the paper.
Corresponding author
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–11, Supplementary Tables 1–3 and Supplementary Methods (PDF 5868 kb)
Rights and permissions
About this article
Cite this article
Bachovchin, D., Brown, S., Rosen, H. et al. Identification of selective inhibitors of uncharacterized enzymes by high-throughput screening with fluorescent activity-based probes. Nat Biotechnol 27, 387–394 (2009). https://doi.org/10.1038/nbt.1531
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.1531
This article is cited by
-
Discovery of small-molecule enzyme activators by activity-based protein profiling
Nature Chemical Biology (2020)
-
Quantitating drug-target engagement in single cells in vitro and in vivo
Nature Chemical Biology (2017)
-
Mechanistic evaluation and transcriptional signature of a glutathione S-transferase omega 1 inhibitor
Nature Communications (2016)
-
Structure, function and disease relevance of Omega-class glutathione transferases
Archives of Toxicology (2016)